Multiple Australian outlets report that oncologists are warning about a potential wave of recurrent cancers linked to delayed diagnoses during the COVID-19 period. The articles describe how patients who would normally have had routine tests or follow-ups postponed screening and medical appointments, and later presented when disease had progressed further. One story follows a patient, identified as Cheryl, who missed tests during COVID and later sought a GP visit after an initial trigger prompted her to get checked. The outlets say clinicians are concerned that these delays can lead to cancers being found at later stages and may contribute to higher rates of recurrence as treatment occurs further along in the disease process.
While the reporting focuses on the human impact of missed screening, all sources connect the individual account to a broader clinical pattern: fewer timely diagnoses during the pandemic, followed by later-stage presentations and increased cancer burden. The articles emphasize the need for patients to return to regular health checks and for health systems to address screening backlogs.
